Mayo Clinic
The purpose of this to evaluate the capability of the FDA approved Medtronic LINQ II device (implantable cardiac monitoring device) to record EEG signals when placed temporarily in the subscalp space in patients undergoing cranial neurosurgery. No disease-directed therapeutic efficacy endpoints will be studied.
Inclusion Criteria: * Patients 18-80 years old. * Undergoing (or expected to undergo) intracranial EEG electrode or deep brain stimulator placement surgery as part of clinical standard of care. Exclusion Criteria: * Patients deemed by the neurosurgery team to be at elevated risk of infection or hemorrhage because of the study procedure. * Individuals who cannot provide informed consent, do not have an available legally authorized representative, or are part of vulnerable or protected populations. * Pregnant or breast-feeding female participants. * Women of childbearing potential will be scr…
Bilateral LINQII devices will be implanted under the scalp during surgery to obtain approximately 30 minutes of brain signal recordings.
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.